Targeting aggressive prostate cancer-associated CD44v6 using phage display selected peptides

There is a crucial need to identify new biomarkers associated with aggressive prostate cancer (PCa) including those associated with cancer stem cells (CSCs). CD44v6, generated by alternative splicing of CD44, has been proposed as a CSC biomarker due to its correlation with aggressive PCa disease. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Ying, Prater, Austin R., Deutscher, Susan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689723/
https://www.ncbi.nlm.nih.gov/pubmed/29156833
http://dx.doi.org/10.18632/oncotarget.21421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689723/
https://www.ncbi.nlm.nih.gov/pubmed/29156833
http://dx.doi.org/10.18632/oncotarget.21421

Ejemplares similares